Cognitive behavioral therapy is an effective treatment for chronic insomnia

June 9, 2009

A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract that will be presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

Results indicate that 50 percent to 60 percent of participants with chronic sleep onset insomnia, sleep maintenance insomnia or both experienced remission of their primary sleep difficulty. Among the 64 participants who completed five or more treatment sessions, there were significant improvements on presenting complaints, as well as all other measures, including sleep efficiency, average nightly awakenings, total sleep time and average nights of sleep medication use per week.

According to lead author Ryan Wetzler, Psy.D, C.B.S.M. of Sleep Medicine Specialists in Louisville, Ky., results of the study indicate that multi-component CBT-I can be an effective approach for those experiencing chronic insomnia even when anxiety and depression are part of the clinical picture.

"CBT-I teaches strategies to 'reset' the bodily systems that regulate sleep," said Wetzler. "Since these systems also play a role in regulation of mood, pain and other bodily processes, skills developed through CBT-I may also have a positive impact on mood, anxiety, pain and other associated medical or psychiatric conditions."

The study gathered data from 115 patients who had visited the Insomnia Treatment Program and Behavioral Sleep Medicine Clinic. Study participants included those with complaints of prolonged (more than 30 minutes) sleep onset latency (SOL), sleep maintenance insomnia (SMI), or both sleep onset and sleep maintenance (SOMI), and who had attended at least two treatment sessions. Participants were between the ages of 14 and 81 years, and 65 percent of the sample was female.

The multi-component, CBT-I program included comprehensive evaluations of patients' habits, attitudes and knowledge concerning sleep. The program was designed to involve six to seven treatment sessions. Specific strategies included education on sleep regulating systems, sleep scheduling recommendations, sleep hygiene education, sleep consolidation therapy, stimulus control therapy, relaxation training, cognitive therapy and mindfulness training.

According to Wetzler, a related study found that of participants who completed at least four treatment sessions of CBT-I, 78 percent of those using sleep medication for three or more nights per week were able to completely discontinue use of sleep medications. Findings from this study indicate that those who discontinued use of sleep medications not only stopped using drugs to sleep but also slept better than when they were taking sleep medications.

Source: American Academy of Medicine (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


June 9, 2009 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

WHO says Tamiflu still works against swine flu

Medicine & Health / Medications

created 6 minutes ago | popularity not rated yet | comments 0

(AP) -- The World Health Organization says isolated cases of drug-resistant swine flu in Britain and the United States have not changed the agency's assessment of the disease.


Scientists reveal 'protector' gene behind 50-fold increase in number of bowel tumours

Medicine & Health / Cancer

created 46 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Cancer Research UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.


newborn, baby

First anti-seizure drug for newborns to be developed

Medicine & Health / Medications

created 31 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Researchers at the UCL Institute for Child Health are developing the first anti-seizure drug specifically for newborn babies, with the aim of reducing brain damage.


An end to sleep problems? Researchers discover enzyme behind effects of sleep deprivation

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration ...


Ginkgo biloba doesn’t prevent cardiovascular events but may have potential peripheral artery disease benefits

Medicine & Health / Research

created 2 hours ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Ginkgo biloba didn’t prevent cardiovascular death or major events such as heart attack and stroke in people age 75 and older, but the herb may affect peripheral vascular disease, according to research reported ...